United Therapeutics Corp/ US91307C1027 /
17.05.2024 21:59:50 | Изменение +2.15 | Объем сделки | Бид- | Предложение- | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
274.31USD | +0.79% | 13,316 Оборот: 3.64 млн |
-Величина цены спроса: - | -Величина цены предложения: - | 12.16 млрдUSD | - | 13.04 |
GlobeNewswire
0:00
ROSEN, A LEADING LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class...
GlobeNewswire
19.05
Music Licensing, Inc. (OTC: SONG) (OTC: SONGD) Announces Implementation of 1-for-500,000 Reverse S...
Newsfile Corp
19.05
Predictive Quantum Artificial Intelligence Lab 1950.Ai Launches to Advance AI through Research and C...
GlobeNewswire
19.05
AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Thera...
GlobeNewswire
19.05
NARI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Inari Medical, Inc. Investors ...
GlobeNewswire
19.05
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Xiao-I Corporation Investors to Inquire About ...
GlobeNewswire
19.05
Evolv Technologies (EVLV) Slashes 2024 Revenue Expectations, Class Action Pending - Hagens Berman
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница